Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

FDA Approves Spectranetics' 0.9 MM Catheter

Facebook Twitter LinkedIn Email Comments
COLORADO SPRINGS, Colo., Aug. 16 -- The Spectranetics Corp. has received the approval of the US Food and Drug Administration to market the Vitesse 0.9-mm rapid exchange disposable catheter in the US. This catheter is used to help repair blood vessels in the heart by delivering excimer laser energy to burn up plaque that is limiting blood flow within coronary arteries as small as 1.5 mm in diameter.
This is an important approval for us, said Joseph A. Largey, CEO of Spectranetics. There are more than 800,000 angioplasty procedures performed in the United States every year, and more than 1.3 million worldwide. One of our constraints in the marketplace has been our inability to offer a small catheter.
Aug 2000
News & Features

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2020 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.